Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-fluciclovine PET Changes in mCRPC
NCT04158245Phase 2Completed
- Sponsor
- Tulane University
- Start
- Jan 2020
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Tulane University. Primary endpoints: Changes in 18F-fluciclovine PET Scan at 12 weeks and PET Scan vs. Conventional CT and Bone Scan at 12 weeks. Started Jan 2020; status: completed.
Beyond the preview
Go deeper on NCT04158245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04158245.